National Bank of Canada’s Medifast MED Stock Holding History

National Bank of Canada’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71	Buy	+7	New	+$75	﹤0.01%	2851
2024 Q4	–	Sell	-9	Closed	-$172	–	3105
2024 Q3	$172	Sell	9 -1	-10%	-$19	﹤0.01%	2536
2024 Q2	$211	Hold	10	–	–	﹤0.01%	2602
2024 Q1	$249	Sell	10 -80	-89%	-$3.88K	﹤0.01%	2628
2023 Q4	$6.32K	Sell	90 -15	-14%	-$1.04K	﹤0.01%	2254
2023 Q3	$7.94K	Sell	105 -8,321	-99%	-$738K	﹤0.01%	2250
2023 Q2	$775K	Sell	8,426 -1,248	-13%	-$111K	﹤0.01%	1208
2023 Q1	$1M	Buy	9,674 +568	+6%	+$62.9K	﹤0.01%	1054
2022 Q4	$974K	Buy	9,106 +3,856	+73%	+$449K	﹤0.01%	1089
2022 Q3	$566K	Sell	5,250 -1,935	-27%	-$277K	﹤0.01%	1136
2022 Q2	$1.3M	Buy	7,185 +385	+6%	+$68.9K	0.01%	923
2022 Q1	$1.16M	Buy	6,800 +496	+8%	+$93.5K	﹤0.01%	1046
2021 Q4	$1.31M	Buy	+6,304	New	+$1.3M	﹤0.01%	952

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

National Bank of Canada's MED Position: Q1 2026 in Review

National Bank of Canada opened a new position in Medifast (MED) in Q1 2026: 7 shares worth $71. The stake represents ﹤0.01% of the portfolio and ranks #2851 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in MED as recently as Q3 2024.

National Bank of Canada first reported a position in MED in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.31M in Q4 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

National Bank of Canada held 7 shares of Medifast worth $71 as of Q1 2026.
Medifast was a new National Bank of Canada position in Q1 2026.
Medifast made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2851 holding.
National Bank of Canada first reported a position in Medifast in Q4 2021 and has held it in 13 quarters since.
National Bank of Canada's Medifast position peaked at $1.31M in Q4 2021.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.